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EDITORIAL
Greetings to all our readers!  This first edition of JEMDSA promises 
to be both insightful and instructive, if not disruptive.  SEMDSA 
(after much consideration and debate) has produced a flurry 
of new (Hypothyroid), updated (Lipid and Osteoporosis) and 
revised (T2 Diabetes) management recommendations. Business 
codes have evolved significantly and apart from providing a 
framework of what is correct and ethical, it is now mandated 
that implementation must ensue – the world has moved from 
providing an idealised tick box (guidelines) to ensuring that on-
the-ground change does in fact happen. The newer guidelines 
(are less misguided) and now provide us practitioners with 
better evidence-based options, but implementation is needed. 
The diabetes epidemic is certainly upon us and modern 
therapies that offer composite care (glucose control with fewer 
hypoglycaemic events and weight reduction) as well protective 
care (fewer cardiovascular events and even less renal disease) 
should be embraced.  So a pat on the back for the elders of the 
guideline committees for taking these first steps in the right 
direction, but a kick somewhere else more distal and posterior 
for taking so long!   
Greetings to all my editorial colleagues as well! Thank you for your 
efforts in reviewing the ever increasing numbers of manuscripts 
submitted to the journal. Please avoid the leisurely pace of the 
elders mentioned above and improve on your response times! 
A special acknowledgement to the many co-opted colleagues 
who assisted me with the reviews – many of the submissions to 
JEMDSA fall out of our comfort areas of “expertise” and reviewing 
manuscripts under these circumstances is seemingly as wretched 
as partaking in a guideline committee meeting! 
None the less we have done well and have published three 
great articles. The World Kidney Day Steering Committee has 
provided a new insight into the link (direct and indirect) between 
obesity and chronic kidney disease – much food for thought and 
importantly much food and more renal replacement therapy is 
the clear message. Androgen deficiency in aging men always 
begets the question – to treat or not to treat? However a step 
yet to be more clearly defined is who to treat? As the number 
of elderly males continues to increase is the developing world 
able to screen androgen deficiency more cost effectively or 
not? Ugwe et al attempt to answer this. Diabetes-related eye 
disease is common and traditionally cataract and retinal disease 
has dominated this aspect of visual morbidity. Mathebula et 
al clearly allude to a lesser appreciated dimension of diabetes 
and abnormal optics and have also provide an insightful 
pathophysiological basis to why pre-presbyopia exists in patients 
with diabetes. 
Happy reading, focus, remember well and enjoy the MCQs. 
Jeffrey  Wing
